Last updated on July 2017

Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).


Brief description of study

Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION).

Detailed Study Description

A Multicenter, Randomized, Open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in subjects with NDD-CKD

Qualified Participants will receive at no cost to them.

  • Study Medication
  • Study Related Labs
  • Physical Exams
  • Rescue Medication
  • Compensation for your time and travel for each completed study visit

    To Lean More about this study and other Chronic Kidney Disease ( CKD) for Non- Dialysis ( NDD) - including Dialysis Dependent ( DD), with or with out Anemia , please go to our contact information below.

    Clinical Study Identifier: TX150858

    Contact Investigators or Research Sites near you

    Start Over

    Roxy

    West Broward Research Institute, LLC
    Lauderdale Lakes, FL USA
      Connect »
  • Recruitment Status: Open


    Brief Description Eligibility Contact Research Team


    Receive Emails About New Clinical Trials!

    Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.